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PRS9
PREDICTORS OF HOSPITALIZATION AND 
EMERGENCY ROOM USE IN A MEDICAID 
MANAGED CARE ASTHMATIC POPULATION
Drabinski AM1, Schaffer M2, Chatterton ML1
1Thomas Jefferson University, Philadelphia, PA, USA; 2Health 
Partners, Philadelphia, PA, USA
OBJECTIVE: To develop a predictive risk-assessment
model for asthmatics of a Medicaid managed care popu-
lation using claims data. The model weighs the predictive
value of commonly collected variables to identify mem-
bers at risk for hospitalizations and emergency room uti-
lization. METHODS: For this retrospective cohort study,
asthmatics continuously enrolled from January 1, 1998
through December 31, 1998 were identified. Asthmatics
were defined as members with: (1) at least one medical
claim with an ICD-9 code (493.00–493.9) for asthma
(between 18–65 years of age) or (2) at least one prescrip-
tion for any asthma-related drug for patients between
18–44 years of age. Patients receiving beta2-agonists must
have had at least 2 prescriptions during the 1-year study
period. Patients were defined as high- or low-risk based
on asthma-related resource use for a 6-month period
(7/1/98–12/31/98). Claims from the prior six months
were used to obtain predictive variables. A multivariate
predictive model was developed using classification and
regression tree analyses. RESULTS: We identified 5299
asthmatics of which 13% (694/5299) were classified as
high-risk. The model identified high-risk patients with a
sensitivity 91%, specificity 27%, positive predictive value
30%. We assigned a higher weight for misclassifying
high-risk verses low-risk recipients. The sensitivity of the
model outperformed individual predictive variables with
the exception of primary care visits. Variables identified
as having relative importance include (in order of impor-
tance): ER utilization, hospitalizations, number of oral
steroid prescriptions, number of asthma prescriptions,
and number of primary care visits. CONCLUSION: We
conclude that claims data can identify high-risk patients
with a high sensitivity, so as to allow for timely interven-
tion. The limitation, however, is poor specificity.
PRS10
ANNUAL COST OF TREATING ASTHMA IN A 
MANAGED CARE POPULATION
Yazdani C1, Stanford R2, McLaughlin T1, Margraf T3
1NDC Health Information Services, Phoenix, AZ, USA; 2Glaxo 
Wellcome Inc, Research Triangle Park, NC, USA; 3PharMetrics, 
Inc., Boston, MA, USA
OBJECTIVE: To determine the average annual cost of
treating asthma in a managed care population. METH-
ODS: All subjects contained within Pharmetric’s Inte-
grated Outcomes database possessing a diagnosis of
asthma (ICD-9-CM  493) during 1996–1998 were eli-
gible for study inclusion. Patients were required to have
12 months of data following the first (index) asthma di-
agnosis present. Patients with the diagnosis of chronic
obstructive pulmonary disease and coronary failure were
excluded. Asthma specific and total medical charges were
captured for the study period, as well as asthma-related
and general hospitalizations. Charges, hospitalization
and emergency department (ED) visit rates were com-
pared across age categories (6–17, 18–44, 45) and gen-
der. RESULTS: 77,603 patients met the inclusion crite-
ria. The mean age was 30.9 years (SE  0.061), and
60.6% of the sample was female. The mean annual
asthma specific charges per patient was $926.68 (SE 
9.59). Inpatient charges accounted for 48.9% of asthma-
related expenses, while outpatient and pharmacy charges
accounted for 25.0% and 24.6% respectively. Asthma-
related costs increased with age (6–17: $683.61; 18–44:
$962.24; 45: $1177.80). 10.0% of the identified pa-
tients were hospitalized for asthma within 12 months of
index diagnosis. The rate of asthma-related hospitaliza-
tion was similar across the three age categories. In addi-
tion, 5.3% of patients visited the ED due to asthma exac-
erbation during the 12 months of observation, with the
rate of ED visits decreasing with age (6–17: 6.11%; 18–44:
5.87%; 45: 3.45%). CONCLUSION: A substantial
portion of asthmatics in this study required inpatient or
emergency room care related to an asthma exacerbation.
As hospitalization for asthma is often considered an
avoidable outcome, these results point to the inadequa-
cies of current preventive asthma treatment.
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INPATIENT UTILIZATION OF MEDICAL 
SERVICES ASSOCIATED WITH PERIPHERAL 
ARTERIAL DISEASE-RELATED INPATIENT 
PROCEDURES IN THE DEPARTMENT OF 
DEFENSE
Zachry WM, Shepherd MD, Wilson JP
The University of Texas at Austin, Austin, TX, USA
OBJECTIVE: The objective of this study was to describe
the inpatient procedural medical care utilization the first
ten years after initial inpatient confirmation of peripheral
arterial disease (PAD). METHODS: We performed a ret-
rospective review of the computer records of all the bene-
ficiaries of the Department of Defense health care system
since 1970. Over 8000 subjects with an initial inpatient
confirmation of PAD between 1/1/80 and 12/31/85 were-
reviewed for ten years following the initial visit. RE-
SULTS: The utilization of PAD-related invasive proce-
dures gradually increased over the first eight years, and
rose sharply in the 9th, and 10th years after initial diagno-
sis. The utilization of examination procedures was high-
est in the 1st, 5th–7th, 9th and 10th years. Procedures involv-
ing bypass and amputation had the highest utilization
among invasive procedures, while procedures involving
arteriography and ultrasonography accounted for 89%
Abstracts 147
of all examination procedures. Bypass and repair of ves-
sel procedures gradually rose throughout the ten years
after initial diagnosis, while amputations and skin grafts
remained relatively constant. Procedures involving arteri-
ography rose until year 5 and then tapered off, while uti-
lization of ultrasonography rose in year 7 and tapered
off. The Point Prevalence of inpatient confirmed PAD
was 2.185/100, and the incidence per 1000 patients for
1993, 1994, and 1995 was 1.09, 1.10, and 1.03 respec-
tively. CONCLUSION: The results of this research pro-
vide a foundation for understanding the ten-year trends
associated with PAD-related inpatient procedural care
utilization. These results suggest that PAD-related studies
should consider the progression of the disease past the 5th
year after the initial inpatient visit for PAD when measur-
ing a change in inpatient procedural outcomes.
PSG2
TEN-YEAR COSTS ASSOCIATED WITH 
PERIPHERAL ARTERIAL DISEASE-RELATED 
INPATIENT PROCEDURES IN THE 
DEPARTMENT OF DEFENSE
Zachry WM, Shepherd MD, Wilson JP, Lawson KA
The University of Texas at Austin, Austin, TX, USA
OBJECTIVE: The objective of this study was to explore
the trends associated with inpatient procedural medical
care costs the first ten years after initial inpatient confir-
mation of peripheral arterial disease (PAD). METHODS:
A retrospective review of the computer records of all the
beneficiaries of the Department of Defense health care
system was conducted, and over 8000 subjects with an
initial inpatient confirmation of PAD between 1/1/80 and
12/31/85 were reviewed for ten years following the initial
visit. 1997 Medicare 50th percentile reimbursement costs
for PAD related procedures were collected and used in
the analysis. Opportunity costs associated with the inpa-
tient procedures performed were also calculated by utiliz-
ing the Bureau of Labor and Statistic’s hospital services
price index, and future value calculations. RESULTS:
Costs for PAD-related invasive procedures rose gradually
over the ten years after initial diagnosis, while the cost of
examination procedures was highest in the 1st, 5th, and
10th years. Invasive procedures made up 85.5% of the to-
tal ten-year procedural costs, with 10 specific ICD-9-CM
codes accounting for 90% of those costs. Four examina-
tion procedures represented 90% of all examination pro-
cedure costs. Procedures involving vascular bypass had
the highest aggregate costs associated with invasive pro-
cedures, and procedures involving arteriography had the
highest aggregate costs associated with examination pro-
cedures. The institution’s opportunity costs were over
one quarter a million 1997 US dollars at a 10 percent
investment rate. CONCLUSION: The results of this re-
search provide a foundation for understanding the ten-
year trends associated with PAD-related inpatient proce-
dural costs. These results suggest that reducing procedures
involving bypass and arteriography would have the
greatest impact on PAD-related procedural costs.
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COSTS INCURRED DURING INPATIENT 
ADMISSION FOR COMMON SURGERIES: 
PRELIMINARY RESULTS
Strassels S1, Chen C2, Carr D1, McDonagh M1, Gouveia W1, 
Wurm H1
1New England Medical Center, Boston, MA, USA; 2Searle 
Pharmaceuticals, Skokie, IL, USA
Recent efforts to limit health care cost increases have fo-
cused on prescription drugs. Although millions of surgi-
cal procedures are performed in the US each year, limited
information is available about perioperative costs in-
curred by persons undergoing surgery. These types of
data are expected to be important to clinicians and deci-
sion-makers as financial pressure increases to define, un-
derstand, and rationalize medical costs. OBJECTIVES:
This pilot study identified the costs associated with inpa-
tient hospitalization after common abdominal or ortho-
pedic surgeries. METHODS: Total costs from admission
until discharge were identified using the hospital perspec-
tive for persons undergoing total abdominal hysterec-
tomy (TAH), or total joint (hip or knee) replacement
(TJR) between August and November 1999. RESULTS:
Patient’s average age was 53.0 years for all patients, 43.7
years for TAH, and 59.1 years for TJR. More than 70%
of participants had private insurance. Average length of
stay was 3.6 days overall, 3.2 days for TAH, and 4.3
days for TJR. Mean total costs were $6596 for all per-
sons (n  8), $5495 for TAH (n  5), and $8431 for TJR
(n  3). Routine room and operating room costs ac-
counted for 72.5%, 76.3%, and 68.3% of the total,
TAH, and TJR costs, respectively. Pharmacy costs ac-
counted for 4.4% of total costs, 5.9% of TAH costs, and
2.8% of TJR costs. CONCLUSIONS: Most of the costs
incurred during the perioperative period are related to
the surgical procedure and per diem costs. Efforts to re-
strict pharmacy costs are unlikely to significantly affect
total costs.
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TRAUMATIC COLON INJURIES: DIFFERENCE IN 
HOSPITAL COSTS BY TYPE OF 
SURGICAL REPAIR
O’Brien J1, Pierce D1, Jacobs L2
1Caro Research, Concord, MA, USA; 2Department of 
Traumatology and Emergency Medicine, Hartford Hospital, 
Hartford, CT, USA
Clinical practice guidelines are advocating the use of pri-
mary repair (PR) for treating a penetrating intra-perito-
neal colon injury when clinically appropriate. OBJEC-
TIVE: To estimate the difference in hospital costs in
treating penetrating colon injuries by PR versus diverting
